about
CD28 expression in sentinel node biopsies from breast cancer patients in comparison with CD3-zeta chain expressionInterleukin-10 increases Th1 cytokine production and cytotoxic potential in human papillomavirus-specific CD8(+) cytotoxic T lymphocytes.Follicular lymphomas can be induced to present alloantigen efficiently: a conceptual model to improve their tumor immunogenicity.Management of malignant melanoma: new developments in immune and gene therapy.Physical exercise and immune system function in cancer survivors: a comprehensive review and future directions.PD-1 gene promoter polymorphisms correlate with a poor prognosis in non-small cell lung cancerPD-1, PD-L1 (B7-H1) and Tumor-Site Immune Modulation Therapy: The Historical Perspective.The combination of chemotherapy and systemic immunotherapy and the concept of cure in murine leukemia and lymphoma.Preoperative sorting of circulating T lymphocytes in patients with esophageal squamous cell carcinoma: its prognostic significance.The evolving role of monoclonal antibodies and dendritic cell therapy in hematologic malignancies.Active specific immunotherapy for colorectal cancer.Strategies for the development of PSA-based vaccines for the treatment of advanced prostate cancer.Human sunlight-induced basal-cell-carcinoma-associated dendritic cells are deficient in T cell co-stimulatory molecules and are impaired as antigen-presenting cellsGene therapy of liver diseases.B7-H1-targeted immunotherapy for head and neck cancer.Distinct roles for CD28 and cytotoxic T lymphocyte-associated molecule-4 receptors during T cell activation?B7-CD28 costimulation unveils the hierarchy of tumor epitopes recognized by major histocompatibility complex class I-restricted CD8+ cytolytic T lymphocytes.Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunityCostimulation by CD48 and B7-1 induces immunity against poorly immunogenic tumors.Antigenic cancer cells grow progressively in immune hosts without evidence for T cell exhaustion or systemic anergyExpression of B7 costimulation molecules by colorectal cancer cells reducestumorigenicity and induces anti-tumor immunity.Enhanced expression of IFN-gamma mRNA in CD4(+)or CD8(+)tumour-infiltrating lymphocytes compared to peripheral lymphocytes in patients with renal cell cancerPreventive effect of ulinastatin on postoperative complications, immunosuppression, and recurrence in esophagectomy patientsImmunology and immunotherapy approaches for prostate cancer.Percutaneous peptide immunization via corneum barrier-disrupted murine skin for experimental tumor immunoprophylaxis.Usage of cancer associated autoantibodies in the detection of diseaseFollowing the fate of individual T cells throughout activation and clonal expansion. Signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response.PD-L1 gene expression in Japanese lung cancer patients.Tumour escape mechanisms and their therapeutic implications in combination tumour therapy.A reversed CD4/CD8 ratio of tumor-infiltrating lymphocytes and a high percentage of CD4(+)FOXP3(+) regulatory T cells are significantly associated with clinical outcome in squamous cell carcinoma of the cervix.Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway.Immunotherapy of colorectal cancer: new perspectives after a long path.Examining T cells at vaccine sites of tumor-bearing hosts provides insights to dysfunctional T-cell immunity.Effects of interferon-α-transduced tumor cell vaccines and blockade of programmed cell death-1 on the growth of established tumors.Can co-stimulated tumor immunity be therapeutically efficacious?Tumor therapy by immune recruitment with bispecific antibodies.Tumor heterogeneity and immunotherapy of cancer.Biological therapy: approaches in colorectal cancer. Strategies to enhance carcinoembryonic antigen (CEA) as an immunogenic targetCD40 expressed on human melanoma cells mediates T cell co-stimulation and tumor cell growth.Interferon-alpha gene therapy in combination with CD80 transduction reduces tumorigenicity and growth of established tumor in poorly immunogenic tumor models.
P2860
Q24808883-CBB04E03-DBB6-43A3-89D2-FCF9DDC11D75Q33804742-4FD53DF4-E6AB-4BB3-9C6E-05D2CCF9C17DQ33956237-0796F8D7-28B9-4764-8B15-A488FD5F7C83Q34067644-721487AF-167C-4C29-8365-144AF688E4ADQ34119107-F944AC8B-4B75-4C7A-9E6D-DADDA69FC2E5Q34265875-E2B1CDF9-38DF-42CB-BC2F-53D8967AE92BQ34550012-C9D6AB98-2235-4763-9D88-317BBCA66202Q35047632-90E74725-0DF3-41CB-BEE7-14DB41BEC7E2Q35165906-7AFF178A-7A02-47CE-BD9B-4BB15E1F51FAQ35173179-0724F4CA-EDFF-4301-89D0-17CEFF316ACCQ35576182-96805DE5-BF78-4BC8-9D0F-05B9D376A931Q35623318-0F047F35-D0FD-4455-9096-EDE7ACCD78D0Q35764615-20C2C855-937A-4DDB-AFA2-3AB7364C9B18Q35842662-008870C1-BB98-476F-84C5-3355EDD4D178Q35907010-C6506ADB-3C39-490B-9662-ED372D373EAAQ36365280-B6F03A94-5F73-4CCF-B7D2-F2C5658AD742Q36365932-155F0400-68B0-4059-A82A-D101465ED674Q36366051-F192F374-4F9E-4C90-B9E1-9B8442B198C2Q36366207-2E4BBFDC-19CD-4C9F-B781-CE717EFDE9EEQ36380365-0B98235C-74F5-4F94-9C00-D9D9E2AC7502Q36396919-7BCD92D0-B5F4-4713-8C0D-F1B30EBDB0F2Q36621847-52340432-8B12-4296-A310-4DE536A511BAQ36767423-EF09F180-3676-40FD-AD80-27FF0C6A105DQ36786512-664B91DE-DF60-4E64-8CEF-4C5DE6B2C3B3Q37153638-5C0F8B55-C00F-4FAF-851C-28305E73BC30Q37217734-F72CF955-EC39-4B73-9BAC-8CCDFD8AF68AQ37376774-B35D9A65-45EC-4FF7-8247-03FD66B4A03AQ37641979-16790BCC-A7F2-453E-9419-D42FE13FD8CFQ37729243-0310AF70-017B-4B2E-BE9C-04B99F02050AQ37729253-F4CB2773-3F64-445D-ABBE-A52CF20D2AEEQ38996832-32419241-02B2-4737-B1AA-68C72700E57CQ39043413-768DC130-3CB9-4AE2-AD79-F5F24C5A22FFQ39232427-0192EE11-16FB-46A7-BE1E-901C3AEFA005Q39315508-68125D7D-814F-4C44-98EF-11DA899A9354Q40433269-840BDC92-D91E-46DE-BFF3-6DFFD45FD867Q40433289-73206639-E85E-4840-B667-393EBB6F5283Q40433328-9224330B-A1C6-4BFD-B1D8-BA4D4B76F876Q40865882-699BB7F5-12D6-47B6-B285-FA276AA8BC34Q40876094-D72E3245-8157-430F-A119-8FC3E48F803EQ40905796-A9837074-3AD5-41C5-95ED-0E919B16A179
P2860
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Costimulation of T cells for tumor immunity.
@en
type
label
Costimulation of T cells for tumor immunity.
@en
prefLabel
Costimulation of T cells for tumor immunity.
@en
P1433
P1476
Costimulation of T cells for tumor immunity
@en
P2093
Hellström KE
Linsley PS
P304
P356
10.1016/0167-5699(93)90262-J
P50
P577
1993-10-01T00:00:00Z